The Allergy Treatment Market to Reach USD 36 Billion by 2030

According to Next Move Strategy Consulting, the Allergy Treatment Market, is set to experience a significant growth trajectory, reaching an estimated USD 36 billion by 2030. This growth reflects a compound annual growth rate (CAGR) of 7% by 2030. This expansion highlights the growing demand for effective solutions to manage allergies, driven by an increasing global prevalence of allergic conditions and advancements in treatment technologies.

Click Here for Your FREE Sample!

Allergy Treatment Market Overview

The allergy treatment market, also known as the allergy therapeutics market, encompasses a broad spectrum of products designed to manage allergic reactions and conditions. These include antihistamines, decongestants, corticosteroids, immunotherapies, and biologics. The industry is focused on the development of medications and therapies to address various allergic conditions like food allergies, eye allergies, skin allergies, asthma, rhinitis, and other forms of hypersensitivity.

Download FREE Sample PDF

Ongoing advancements in medication development, personalized medicine strategies, and cutting-edge research into allergy diagnostics are key trends that are driving the market forward. These innovations are improving the effectiveness of treatments and enhancing patient outcomes by offering tailored therapeutic options. Moreover, allergy treatments are designed not only to relieve symptoms but also to improve the quality of life for allergy sufferers, mitigate the risks of severe allergic reactions, and offer preventive solutions.

Market Dynamics and Trends

1. Rising Incidence of Allergies:

The increasing global prevalence of allergies is a major driver behind the demand for allergy treatments. According to the Global Allergy & Airways Patient Platform (GAA), around 30% to 40% of the global population experiences one or more allergic conditions, a number that has risen in recent years due to environmental changes, pollution, and lifestyle factors. As a result, the demand for allergy medications, diagnostics, and therapies continues to surge.

2. Advancements in Research and Development:

There has been a notable increase in research and development focused on allergy treatments. Regulatory bodies are accelerating approvals for new drugs and therapies, resulting in innovations such as personalized treatments for specific allergens.

For instance, in February 2024, the U.S. Food and Drug Administration (FDA) approved Xolair, the first and only medicine aimed at reducing one or more food allergies in both children and adults. This approval exemplifies the growing sophistication of allergy treatment options and their increasing role in precision medicine.

3. Aging Population and Allergies:

The global aging population is another significant factor driving the growth of the allergy treatment market. As individuals age, their immune systems weaken, making them more susceptible to allergies. The United Nations Population Fund reports that the number of people aged 65 and older has increased significantly over the years and is expected to rise further. This demographic shift is expected to fuel demand for allergy therapeutics as older adults require solutions to manage allergic reactions that may result from compromised immune systems or the presence of chronic diseases.

4. The Emergence of Personalized Immunotherapy:

Personalized immunotherapy is gaining traction as a promising solution to treat allergies more effectively. This treatment approach tailors therapeutic interventions to individual patients based on their specific allergens and immune response. By providing more effective and lasting relief while minimizing adverse effects, personalized immunotherapy is set to revolutionize allergy treatment and drive the market forward.

Market Segmentation and Scope of Study

The global allergy treatment market is segmented based on type, treatment method, end-users, distribution channels, and regions:

By Type:

• Eye Allergy
• Food Allergy
• Skin Allergy
• Asthma
• Rhinitis
• Others

By Treatment:

• Anti-Allergy Drugs
• Immunotherapy

By End-User:

• Hospitals
• Specialty Clinics
• Homecare
• Others

By Distribution Channel:

• Online Pharmacies
• Offline Pharmacies

By Region:

• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Geographical Insights

1. North America:

North America is the largest and fastest-growing market for allergy treatments, largely due to the high prevalence of allergic conditions across the region. In 2023, over 50 million people in the United States were diagnosed with allergies, with the number expected to rise in the coming years. This escalating allergy burden has intensified the need for advanced allergy therapeutics.

Furthermore, government initiatives, such as Canada’s investment of approximately USD 33.96 million towards a National Food Allergy Action Plan, are also contributing to the growth of the allergy treatment market in the region.

2. Asia-Pacific:

The Asia-Pacific region is projected to see steady growth in the allergy treatment market, particularly due to the rising elderly population in countries such as Japan and China. Aging populations are increasingly vulnerable to allergic reactions, which in turn raises the demand for effective allergy treatments.

In addition, the introduction of advanced diagnostic tools, such as AI-powered allergy testing, is expected to improve the accessibility of allergy treatments in this region. For example, Metropolis launched a Component Resolved Diagnostics platform in India in 2023, helping clinicians detect allergens with greater precision.

Competitive Landscape

The allergy treatment market is highly competitive, with numerous players dominating the industry. Key players include:

• Glenmark Pharmaceuticals Ltd.
• Perrigo Company plc
• GlaxoSmithKline plc
• Merck & Co., Inc.
• AbbVie Inc.
• Johnson & Johnson
• Novartis International AG
• Hikma Pharmaceuticals plc
• Bausch Health Companies Inc.

These companies are adopting a variety of strategies, including product launches, partnerships, and the development of innovative therapies to strengthen their market presence. For instance, Entod Pharmaceutical Ltd. introduced Lactoshield RH in March 2024, a probiotic designed for managing rhinitis, offering a non-pharmacological option for allergy management. Similarly, Hikma Pharmaceuticals launched Ryaltris in 2022 to treat seasonal allergic rhinitis, further expanding its portfolio of nasal-administered medications.

Key Benefits and Market Outlook

This study provides a detailed quantitative analysis of the allergy treatment market, offering key insights into prevailing market opportunities and growth drivers. The market is expected to grow at a CAGR of 6.7% from 2024 to 2030, driven by the increasing global prevalence of allergic conditions, advancements in allergy research, and the rise of personalized treatments.

Furthermore, the report provides a deep dive into market trends, key drivers, and constraints, offering stakeholders valuable insights to make informed decisions. Competitive analysis, including SWOT analysis and Porter’s Five Forces model, also provides an understanding of the dynamics at play in the allergy treatment industry.

Conclusion

The allergy treatment market is poised for substantial growth, driven by the rising prevalence of allergies, advancements in research, and the growing aging population. As the demand for personalized treatments and improved diagnostic capabilities increases, the market will continue to evolve, offering better and more effective therapeutic options for allergy sufferers worldwide.

About Next Move Strategy Consulting:

Next Move Strategy Consulting is a premier market research and management consulting firm that has been committed to provide strategically analyzed well documented latest research reports to its clients. The research industry is flooded with many firms to choose from, what makes Next Move different from the rest is its top-quality research and the obsession of turning data into knowledge by dissecting every Bit of it and providing fact-based research recommendation that is supported by information collected from over 500 million websites, paid databases, industry journals and one on one consultations with industry experts across a diverse range of industry sectors.

The high-quality customized research reports with actionable insights and excellent end-to-end customer service help our clients to take critical business decisions that enables them to move beyond time and have competitive edge in the industry. We have been servicing over 1000 customers globally that includes 90% of the Fortune 500 companies over a decade. Our analysts are constantly tracking various high growth markets and identifying hidden opportunities in each sector or the industry. We provide one of the industry’s best quality syndicates as well as custom research reports across 10 different industry verticals. We are committed to deliver high quality research solutions in accordance to your business needs. Our industry standard delivery Solutions that range from the pre consultation to after-sales services, provide an excellent client Experience and ensure right strategic decision making for businesses

Summary:

The allergy treatment market is experiencing robust growth. This expansion is driven by a rise in allergic conditions, ongoing advancements in treatment modalities, and the growing demand for personalized therapeutics. With key players like Glenmark Pharmaceuticals and Merck & Co. leading the way, the industry is set to benefit from innovations in drug development and diagnostic technologies. The North American region is expected to dominate the market, while Asia-Pacific shows significant growth potential due to its aging population and the introduction of advanced diagnostic solutions.